首页> 外文期刊>Acta Crystallographica Section E: Crystallographic Communications >Crystal structure of (S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-hy­droxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta[a]phenanthren-17-yl]-N-meth­oxy-N-methyl­pro­pan­amide (Fernholz Weinreb amide)
【24h】

Crystal structure of (S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-hy­droxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta[a]phenanthren-17-yl]-N-meth­oxy-N-methyl­pro­pan­amide (Fernholz Weinreb amide)

机译:(S)-2-[((3S,8S,9S,10R,13S,14S,17R)-3-羟基-10,13-二甲基-2,3,4,7,8,9,10, 11,12,13,14,15,16,17-十四氢-1H-环戊[a]菲基-17-基] -N-甲氧基-N-甲基丙酰胺(Fernholz Weinreb酰胺)

获取原文
           

摘要

The literature compound 3β-hy­droxy-bis­nor-5-cholenic aldehyde is an important inter­mediate for the synthesis of new modulators of the nuclear oxysterol receptor Liver X. As part of our ongoing search for new LXR antagonists, the title compound, C24H39NO3, has proven to be an important inter­mediate in our new synthetic pathway, giving the corresponding aldehyde in high yield and in only three steps from the commercially available 3β-hy­droxy-bis­nor-5-cholenic acid. The title amide crystallized with two mol­ecules in the asymmetric unit, linked into helices by O—H⋯O hydrogen bonds involving the hy­droxy and carbonyl groups.
机译:文献中的化合物3β-羟基-双去甲-5-胆甾醛是合成核氧固醇受体肝脏X的新调节剂的重要中间体。在我们不断寻求新的LXR拮抗剂的过程中,已证明标题化合物C24H39NO3成为我们新合成途径中的重要中间体,只需3个步骤,即可从市售3β-羟基-双去甲-5-胆酸中获得高产率的相应醛。用在不对称单元中的两个分子结晶的标题酰胺,通过涉及羟基和羰基的OH-H = O氢键连接成螺旋。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号